ノエビア HD（4928）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
|---|---|---|---|---|
| 売上高 | 2013/09 | 135億 | 313億 | 16.9億 |
| 2014/09 | 141億 +3.8% | 321億 +2.6% | 20.9億 +23.5% | |
| 2015/09 | 135億 -4.3% | 340億 +6% | 19.2億 -8% | |
| 2016/09 | 132億 -1.6% | 360億 +5.9% | 19.1億 -0.7% | |
| 2017/09 | 135億 +1.9% | 392億 +8.8% | 17.9億 -6.1% | |
| 2018/09 | 132億 -2.1% | 426億 +8.7% | 20.1億 +12.6% | |
| 2019/09 | 120億 -8.8% | 452億 +6% | 20.4億 +1.4% | |
| 2020/09 | 113億 -6.3% | 387億 -14.2% | 18.3億 -10.6% | |
| 2021/09 | 111億 -1.4% | 383億 -1.1% | 18.3億 +0.2% | |
| 2022/09 | 114億 +2.6% | 470億 +22.7% | 27億 +47.9% | |
| 2023/09 | 120億 +5.1% | 482億 +2.4% | 23.9億 -11.5% | |
| 2024/09 | 114億 -4.5% | 498億 +3.3% | 26.2億 +9.5% | |
| 2025/09 | 115億 +0.8% | 505億 +1.5% | 26.6億 +1.8% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 営業利益 | 2013/09 | 13億 | 77.8億 | 3.9百万 |
| 2014/09 | 6.74億 -48% | 84.1億 +8.2% | -158百万 赤字 | |
| 2015/09 | 10.1億 +50.1% | 87.1億 +3.5% | -241百万 赤字 | |
| 2016/09 | 1.7億 -83.2% | 95.4億 +9.6% | -63百万 赤字 | |
| 2017/09 | 7.45億 +338.2% | 110億 +15.4% | 128百万 | |
| 2018/09 | 13.1億 +75.7% | 122億 +10.5% | 135百万 +5.5% | |
| 2019/09 | 13.1億 +0.2% | 132億 +8.5% | 70百万 -48.1% | |
| 2020/09 | 12.6億 -3.9% | 95.1億 -27.9% | 10百万 -85.7% | |
| 2021/09 | 14.4億 +14.4% | 96億 +1% | 156百万 +999.99% | |
| 2022/09 | 11.6億 -19.8% | 108億 +12.6% | 381百万 +144.2% | |
| 2023/09 | 11.9億 +2.4% | 119億 +9.7% | 260百万 -31.8% | |
| 2024/09 | 12.3億 +3.8% | 122億 +3% | 330百万 +26.9% | |
| 2025/09 | 9.8億 -20.3% | 123億 +0.5% | 301百万 -8.8% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 営業利益率 | 2013/09 | 9.6% | 24.9% | 0.2% |
| 2014/09 | 4.8% -4.8% | 26.2% +1.3% | -7.6% 赤字 | |
| 2015/09 | 7.5% +2.7% | 25.6% -0.6% | -12.6% 赤字 | |
| 2016/09 | 1.3% -6.2% | 26.5% +0.9% | -3.3% 赤字 | |
| 2017/09 | 5.5% +4.2% | 28.1% +1.6% | 7.2% | |
| 2018/09 | 9.9% +4.4% | 28.5% +0.4% | 6.7% -0.5% | |
| 2019/09 | 10.9% +1% | 29.2% +0.7% | 3.4% -3.3% | |
| 2020/09 | 11.2% +0.3% | 24.5% -4.7% | 0.5% -2.9% | |
| 2021/09 | 13% +1.8% | 25% +0.5% | 8.5% +8% | |
| 2022/09 | 10.1% -2.9% | 23% -2% | 14.1% +5.6% | |
| 2023/09 | 9.9% -0.2% | 24.6% +1.6% | 10.9% -3.2% | |
| 2024/09 | 10.7% +0.8% | 24.6% ±0% | 12.6% +1.7% | |
| 2025/09 | 8.5% -2.2% | 24.3% -0.3% | 11.3% -1.3% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 研究開発費 | 2013/09 | - | - | - |
| 2014/09 | - | - | - | |
| 2015/09 | - | - | - | |
| 2016/09 | - | - | - | |
| 2017/09 | - | - | - | |
| 2018/09 | - | - | - | |
| 2019/09 | 125百万 | 9.72億 | - | |
| 2020/09 | 133百万 +6.4% | 9.31億 -4.2% | - | |
| 2021/09 | 135百万 +1.5% | 9.05億 -2.8% | - | |
| 2022/09 | 133百万 -1.5% | 9.29億 +2.7% | - | |
| 2023/09 | 128百万 -3.8% | 9億 -3.1% | - | |
| 2024/09 | 122百万 -4.7% | 9.43億 +4.8% | - | |
| 2025/09 | 125百万 +2.5% | 10.1億 +7% | - | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 設備投資額 | 2013/09 | - | - | - |
| 2014/09 | - | - | - | |
| 2015/09 | - | - | - | |
| 2016/09 | - | - | - | |
| 2017/09 | - | - | - | |
| 2018/09 | - | - | - | |
| 2019/09 | 264百万 | 16.6億 | 104百万 | |
| 2020/09 | 237百万 -10.2% | 12.2億 -26.7% | 35百万 -66.3% | |
| 2021/09 | 114百万 -51.9% | 4.17億 -65.7% | 7百万 -80% | |
| 2022/09 | 206百万 +80.7% | 3.97億 -4.8% | 1百万 -85.7% | |
| 2023/09 | 268百万 +30.1% | 5.03億 +26.7% | 202百万 +999.99% | |
| 2024/09 | 141百万 -47.4% | 8.28億 +64.6% | 66百万 -67.3% | |
| 2025/09 | 340百万 +141.1% | 22.1億 +166.8% | 5百万 -92.4% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 固定資産増加額 | 2013/09 | 1.92億 | 5.06億 | 0.03億 |
| 2014/09 | 2.89億 +50.2% | 8.88億 +75.5% | 18.6億 +999.99% | |
| 2015/09 | 18.3億 +531.5% | 13.5億 +52.4% | 0.63億 -96.6% | |
| 2016/09 | 22.3億 +22% | 21.3億 +57.3% | 0.01億 -98.4% | |
| 2017/09 | 2.74億 -87.7% | 12.2億 -42.7% | 0.25億 +999.99% | |
| 2018/09 | 2.22億 -19% | 11.3億 -7.1% | 0.44億 +76% | |
| 2019/09 | 2.64億 +18.9% | 16.6億 +46.6% | 1.04億 +136.4% | |
| 2020/09 | 2.37億 -10.2% | 12.2億 -26.7% | 0.35億 -66.3% | |
| 2021/09 | 1.14億 -51.9% | 4.17億 -65.7% | 0.07億 -80% | |
| 2022/09 | 2.06億 +80.7% | 3.97億 -4.8% | 0.01億 -85.7% | |
| 2023/09 | 2.68億 +30.1% | 5.03億 +26.7% | 2.02億 +999.99% | |
| 2024/09 | 1.41億 -47.4% | 8.28億 +64.6% | 0.66億 -67.3% | |
| 2025/09 | 3.4億 +141.1% | 22.1億 +166.8% | 0.05億 -92.4% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 従業員数 | 2013/09 | - | - | - |
| 2014/09 | - | - | - | |
| 2015/09 | - | - | - | |
| 2016/09 | - | - | - | |
| 2017/09 | - | - | - | |
| 2018/09 | - | - | - | |
| 2019/09 | 449 | 912 | 64 | |
| 2020/09 | 460 +2.4% | 884 -3.1% | 63 -1.6% | |
| 2021/09 | 443 -3.7% | 878 -0.7% | 67 +6.3% | |
| 2022/09 | 425 -4.1% | 862 -1.8% | 65 -3% | |
| 2023/09 | 414 -2.6% | 843 -2.2% | 62 -4.6% | |
| 2024/09 | 394 -4.8% | 861 +2.1% | 65 +4.8% | |
| 2025/09 | 390 -1% | 850 -1.3% | 65 ±0% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 平均臨時雇用人員 | 2013/09 | - | - | - |
| 2014/09 | - | - | - | |
| 2015/09 | - | - | - | |
| 2016/09 | - | - | - | |
| 2017/09 | - | - | - | |
| 2018/09 | - | - | - | |
| 2019/09 | 26 | 125 | 13 | |
| 2020/09 | 26 ±0% | 117 -6.4% | 8 -38.5% | |
| 2021/09 | 28 +7.7% | 123 +5.1% | 8 ±0% | |
| 2022/09 | 28 ±0% | 128 +4.1% | 10 +25% | |
| 2023/09 | 30 +7.1% | 134 +4.7% | 12 +20% | |
| 2024/09 | 28 -6.7% | 137 +2.2% | 14 +16.7% | |
| 2025/09 | 26 -7.1% | 135 -1.5% | 14 ±0% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 資産 | 2013/09 | 193億 | 601億 | 25.5億 |
| 2014/09 | 204億 +5.9% | 592億 -1.6% | 40.9億 +60.7% | |
| 2015/09 | 222億 +8.6% | 585億 -1.1% | 40.9億 -0.2% | |
| 2016/09 | 227億 +2.4% | 575億 -1.7% | 13.6億 -66.8% | |
| 2017/09 | 229億 +0.8% | 572億 -0.5% | 14.5億 +7.2% | |
| 2018/09 | 201億 -12.4% | 532億 -7.1% | 13.1億 -10% | |
| 2019/09 | 178億 -11.2% | 553億 +4% | 23.9億 +82.6% | |
| 2020/09 | 162億 -8.8% | 536億 -3.2% | 25億 +4.6% | |
| 2021/09 | 174億 +7.2% | 534億 -0.3% | 24.7億 -1% | |
| 2022/09 | 168億 -3.8% | 506億 -5.3% | 27.2億 +10% | |
| 2023/09 | 169億 +0.8% | 500億 -1.1% | 25.8億 -5.1% | |
| 2024/09 | 156億 -7.4% | 507億 +1.2% | 27億 +4.7% | |
| 2025/09 | 143億 -8.3% | 504億 -0.5% | 24.9億 -7.9% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| 減損損失 | 2013/09 | - | - | - |
| 2014/09 | 27百万 | - | - | |
| 2015/09 | - | - | - | |
| 2016/09 | - | - | - | |
| 2017/09 | 10百万 | 189百万 | - | |
| 2018/09 | - | - | - | |
| 2019/09 | - | - | - | |
| 2020/09 | - | - | - | |
| 2021/09 | - | - | - | |
| 2022/09 | 27百万 | 276百万 | 6百万 | |
| 2023/09 | - | - | - | |
| 2024/09 | - | - | - | |
| 2025/09 | - | - | - | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| のれん | 2013/09 | - | - | - |
| 2014/09 | 163百万 | 7百万 | - | |
| 2015/09 | 134百万 -17.8% | 6百万 -14.3% | - | |
| 2016/09 | 90百万 -32.8% | 4百万 -33.3% | - | |
| 2017/09 | 46百万 -48.9% | 2百万 -50% | - | |
| 2018/09 | 2百万 -95.7% | 0 | - | |
| 2019/09 | - | - | 302百万 | |
| 2020/09 | - | - | 271百万 -10.3% | |
| 2021/09 | - | - | 240百万 -11.4% | |
| 2022/09 | - | - | 209百万 -12.9% | |
| 2023/09 | - | - | 178百万 -14.8% | |
| 2024/09 | 10百万 | 0 | 147百万 -17.4% | |
| 2025/09 | 8百万 -20% | 0 | 116百万 -21.1% | |
| 科目 | 年度 | 医薬・食品事業 | 化粧品事業 | その他 |
| のれん償却額 | 2013/09 | - | - | - |
| 2014/09 | 40百万 | 1百万 | - | |
| 2015/09 | 43百万 +7.5% | 2百万 +100% | - | |
| 2016/09 | 43百万 ±0% | 2百万 ±0% | - | |
| 2017/09 | 43百万 ±0% | 2百万 ±0% | - | |
| 2018/09 | 43百万 ±0% | 2百万 ±0% | - | |
| 2019/09 | 2百万 -95.3% | 0 | 7百万 | |
| 2020/09 | - | - | 31百万 +342.9% | |
| 2021/09 | - | - | 31百万 ±0% | |
| 2022/09 | - | - | 31百万 ±0% | |
| 2023/09 | - | - | 31百万 ±0% | |
| 2024/09 | 0 | 0 | 31百万 ±0% | |
| 2025/09 | 2百万 | 0 | 31百万 ±0% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 医薬・食品事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/09 | 34.9億 | 31.6億 | 33億 | 41.3億 | 141億 |
| 2015/09 | 30.2億 -13.4% | 31.7億 +0.3% | 33億 +0.1% | 39.7億 -3.7% | 135億 -4.3% | |
| 2016/09 | 33.6億 +11.1% | 24.9億 -21.3% | 32.3億 -2.1% | 41.7億 +4.9% | 132億 -1.6% | |
| 2017/09 | 31.9億 -4.9% | 30.8億 +23.7% | 34.5億 +6.7% | 37.7億 -9.5% | 135億 +1.9% | |
| 2018/09 | 31.5億 -1.4% | 30.5億 -0.9% | 31.7億 -8.1% | 38.3億 +1.6% | 132億 -2.1% | |
| 2019/09 | 31.3億 -0.8% | 28億 -8.3% | 30.6億 -3.5% | 30.5億 -20.2% | 120億 -8.8% | |
| 2020/09 | 28.6億 -8.4% | 27.3億 -2.4% | 26.1億 -14.8% | 30.7億 +0.6% | 113億 -6.3% | |
| 2021/09 | 27.8億 -3.1% | 25.8億 -5.5% | 27.2億 +4.3% | 30.4億 -0.9% | 111億 -1.4% | |
| 2022/09 | 26.3億 -5.3% | 28.2億 +9.2% | 27.5億 +1.3% | 32.1億 +5.5% | 114億 +2.6% | |
| 2023/09 | 27.9億 +6.1% | 27.9億 -1.1% | 30.7億 +11.5% | 33.4億 +4.1% | 120億 +5.1% | |
| 2024/09 | 27.6億 -0.9% | 27.4億 -2% | - | - | - | |
| 営業利益 1Q2Q 3Q | 2014/09 | 1.48億 | 2.67億 | 0.39億 | 2.2億 | 6.74億 |
| 2015/09 | 1.63億 +10.1% | 2.97億 +11.2% | 2.16億 +453.8% | 3.36億 +52.7% | 10.1億 +50.1% | |
| 2016/09 | -1.85億 赤字 | 0.64億 -78.5% | 0.55億 -74.5% | 2.36億 -29.8% | 1.7億 -83.2% | |
| 2017/09 | 1.5億 | 0.96億 +50% | 6.07億 +999.99% | -1.08億 赤字 | 7.45億 +338.2% | |
| 2018/09 | 2.4億 +60% | 3.09億 +221.9% | 2.7億 -55.5% | 4.9億 | 13.1億 +75.7% | |
| 2019/09 | 3.55億 +47.9% | 3.21億 +3.9% | 3.78億 +40% | 2.58億 -47.3% | 13.1億 +0.2% | |
| 2020/09 | 3.48億 -2% | 3.4億 +5.9% | 3.03億 -19.8% | 2.7億 +4.7% | 12.6億 -3.9% | |
| 2021/09 | 4.4億 +26.4% | 2.51億 -26.2% | 3.77億 +24.4% | 3.74億 +38.5% | 14.4億 +14.4% | |
| 2022/09 | 3.65億 -17% | 4.01億 +59.8% | 1.61億 -57.3% | 2.3億 -38.5% | 11.6億 -19.8% | |
| 2023/09 | 4.07億 +11.5% | 1.35億 -66.3% | 4.61億 +186.3% | 1.82億 -20.9% | 11.9億 +2.4% | |
| 2024/09 | 4.15億 +2% | 2.68億 +98.5% | - | - | - | |
| 営業利益率 | 2014/09 | 4.2% | 8.5% | 1.2% | 5.3% | 4.8% |
| 2015/09 | 5.4% +1.2% | 9.4% +0.9% | 6.5% +5.3% | 8.5% +3.2% | 7.5% +2.7% | |
| 2016/09 | -5.5% 赤字 | 2.6% -6.8% | 1.7% -4.8% | 5.7% -2.8% | 1.3% -6.2% | |
| 2017/09 | 4.7% | 3.1% +0.5% | 17.6% +15.9% | -2.9% 赤字 | 5.5% +4.2% | |
| 2018/09 | 7.6% +2.9% | 10.1% +7% | 8.5% -9.1% | 12.8% | 9.9% +4.4% | |
| 2019/09 | 11.4% +3.8% | 11.5% +1.4% | 12.4% +3.9% | 8.4% -4.4% | 10.9% +1% | |
| 2020/09 | 12.2% +0.8% | 12.4% +0.9% | 11.6% -0.8% | 8.8% +0.4% | 11.2% +0.3% | |
| 2021/09 | 15.9% +3.7% | 9.7% -2.7% | 13.9% +2.3% | 12.3% +3.5% | 13% +1.8% | |
| 2022/09 | 13.9% -2% | 14.2% +4.5% | 5.9% -8% | 7.2% -5.1% | 10.1% -2.9% | |
| 2023/09 | 14.6% +0.7% | 4.8% -9.4% | 15% +9.1% | 5.5% -1.7% | 9.9% -0.2% | |
| 2024/09 | 15% +0.4% | 9.8% +5% | - | - | - | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 化粧品事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/09 | 91.8億 | 82億 | 78.9億 | 68.3億 | 321億 |
| 2015/09 | 95.3億 +3.8% | 69.7億 -15% | 98.3億 +24.5% | 76.9億 +12.7% | 340億 +6% | |
| 2016/09 | 106億 +11.5% | 76.4億 +9.6% | 100億 +2% | 77.5億 +0.8% | 360億 +5.9% | |
| 2017/09 | 112億 +5.8% | 82.5億 +7.9% | 107億 +6.7% | 90.2億 +16.4% | 392億 +8.8% | |
| 2018/09 | 122億 +8.3% | 91.1億 +10.5% | 116億 +8.5% | 97.3億 +7.8% | 426億 +8.7% | |
| 2019/09 | 125億 +2.7% | 99.4億 +9.1% | 118億 +1.9% | 109億 +12.2% | 452億 +6% | |
| 2020/09 | 122億 -2.8% | 90.3億 -9.2% | 90.4億 -23.6% | 85.2億 -21.9% | 387億 -14.2% | |
| 2021/09 | 109億 -10% | 87.3億 -3.4% | 99.2億 +9.7% | 87.5億 +2.7% | 383億 -1.1% | |
| 2022/09 | 128億 +16.7% | 110億 +25.9% | 122億 +23.4% | 110億 +26.2% | 470億 +22.7% | |
| 2023/09 | 131億 +2.6% | 110億 +0.1% | 125億 +2.1% | 116億 +4.8% | 482億 +2.4% | |
| 2024/09 | 135億 +3.1% | 116億 +5.5% | - | - | - | |
| 営業利益 1Q2Q 3Q | 2014/09 | 29.7億 | 22億 | 18.6億 | 13.9億 | 84.1億 |
| 2015/09 | 29.6億 -0.3% | 12.8億 -41.8% | 31.1億 +67.1% | 13.6億 -2.1% | 87.1億 +3.5% | |
| 2016/09 | 34.7億 +17.2% | 13.8億 +8.2% | 31.6億 +1.7% | 15.3億 +12.2% | 95.4億 +9.6% | |
| 2017/09 | 36.6億 +5.4% | 18億 +30% | 35.4億 +12% | 20.1億 +31.9% | 110億 +15.4% | |
| 2018/09 | 42.5億 +16.4% | 21.2億 +17.6% | 35.6億 +0.5% | 22.3億 +10.9% | 122億 +10.5% | |
| 2019/09 | 43.3億 +1.7% | 22.9億 +8.1% | 36.6億 +3% | 29.1億 +30.4% | 132億 +8.5% | |
| 2020/09 | 37.2億 -14.1% | 19.7億 -14% | 23.4億 -36% | 14.8億 -49.1% | 95.1億 -27.9% | |
| 2021/09 | 32.7億 -12% | 18.5億 -5.8% | 27.4億 +16.8% | 17.4億 +17.6% | 96億 +1% | |
| 2022/09 | 30億 -8.3% | 24.4億 +31.5% | 30.7億 +12.1% | 23.1億 +32.9% | 108億 +12.6% | |
| 2023/09 | 34.6億 +15.2% | 27.2億 +11.6% | 31.5億 +2.8% | 25.4億 +9.9% | 119億 +9.7% | |
| 2024/09 | 36.7億 +6.3% | 28.3億 +4.3% | - | - | - | |
| 営業利益率 | 2014/09 | 32.3% | 26.8% | 23.6% | 20.3% | 26.2% |
| 2015/09 | 31.1% -1.2% | 18.3% -8.5% | 31.6% +8% | 17.7% -2.6% | 25.6% -0.6% | |
| 2016/09 | 32.7% +1.6% | 18.1% -0.2% | 31.5% -0.1% | 19.7% +2% | 26.5% +0.9% | |
| 2017/09 | 32.5% -0.2% | 21.8% +3.7% | 33.1% +1.6% | 22.3% +2.6% | 28.1% +1.6% | |
| 2018/09 | 35% +2.5% | 23.2% +1.4% | 30.6% -2.5% | 22.9% +0.6% | 28.5% +0.4% | |
| 2019/09 | 34.6% -0.4% | 23% -0.2% | 30.9% +0.3% | 26.7% +3.8% | 29.2% +0.7% | |
| 2020/09 | 30.6% -4% | 21.8% -1.2% | 25.9% -5% | 17.4% -9.3% | 24.5% -4.7% | |
| 2021/09 | 29.9% -0.7% | 21.2% -0.6% | 27.6% +1.7% | 19.9% +2.5% | 25% +0.5% | |
| 2022/09 | 23.5% -6.4% | 22.2% +1% | 25% -2.6% | 20.9% +1% | 23% -2% | |
| 2023/09 | 26.4% +2.9% | 24.7% +2.5% | 25.2% +0.2% | 22% +1.1% | 24.6% +1.6% | |
| 2024/09 | 27.2% +0.8% | 24.4% -0.3% | - | - | - | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| その他 | ||||||
| 売上高 1Q2Q 3Q | 2014/09 | 1.46億 | 4.28億 | 8.23億 | 6.88億 | 20.9億 |
| 2015/09 | 2.03億 +39% | 7.51億 +75.5% | 3.26億 -60.4% | 6.38億 -7.3% | 19.2億 -8% | |
| 2016/09 | 1.64億 -19.2% | 6.59億 -12.3% | 3.48億 +6.7% | 7.34億 +15% | 19.1億 -0.7% | |
| 2017/09 | 2.38億 +45.1% | 7.24億 +9.9% | 2.86億 -17.8% | 5.4億 -26.4% | 17.9億 -6.1% | |
| 2018/09 | 0.85億 -64.3% | 8.69億 +20% | 4.61億 +61.2% | 5.98億 +10.7% | 20.1億 +12.6% | |
| 2019/09 | 6.05億 +611.8% | 5.13億 -41% | 2.49億 -46% | 6.74億 +12.7% | 20.4億 +1.4% | |
| 2020/09 | 4.56億 -24.6% | 5.52億 +7.6% | 2.84億 +14.1% | 5.33億 -20.9% | 18.3億 -10.6% | |
| 2021/09 | 1.67億 -63.4% | 6.78億 +22.8% | 3.26億 +14.8% | 6.57億 +23.3% | 18.3億 +0.2% | |
| 2022/09 | 1.89億 +13.2% | 7.78億 +14.7% | 7.33億 +124.8% | 10億 +52.7% | 27億 +47.9% | |
| 2023/09 | 3.32億 +75.7% | 8.93億 +14.8% | 4.09億 -44.2% | 7.57億 -24.5% | 23.9億 -11.5% | |
| 2024/09 | 3.51億 +5.7% | 6.73億 -24.6% | 8.49億 +107.6% | 7.45億 -1.6% | 26.2億 +9.5% | |
| 2025/09 | 3億 -14.5% | 6.98億 +3.7% | 4.97億 -41.5% | 11.7億 +56.9% | 26.6億 +1.8% | |
| 2026/09 *ヶ月 | 3.08億 +2.7% | 7.49億 +7.3% | - | - | - | |
| 営業利益 1Q2Q 3Q | 2014/09 | -69百万 | 50百万 | -97百万 | -42百万 | -158百万 |
| 2015/09 | -105百万 赤字 | -17百万 赤字 | -72百万 赤字 | -47百万 赤字 | -241百万 赤字 | |
| 2016/09 | -104百万 赤字 | 18百万 | -37百万 赤字 | 60百万 | -63百万 赤字 | |
| 2017/09 | -21百万 赤字 | 81百万 +350% | 11百万 | 57百万 -5% | 128百万 | |
| 2018/09 | -38百万 赤字 | 82百万 +1.2% | 78百万 +609.1% | 13百万 -77.2% | 135百万 +5.5% | |
| 2019/09 | -22百万 赤字 | 68百万 -17.1% | -9百万 赤字 | 33百万 +153.8% | 70百万 -48.1% | |
| 2020/09 | 27百万 | 65百万 -4.4% | -106百万 赤字 | 24百万 -27.3% | 10百万 -85.7% | |
| 2021/09 | 16百万 -40.7% | 71百万 +9.2% | -22百万 赤字 | 91百万 +279.2% | 156百万 +999.99% | |
| 2022/09 | 23百万 +43.8% | 143百万 +101.4% | 67百万 | 148百万 +62.6% | 381百万 +144.2% | |
| 2023/09 | 49百万 +113% | 115百万 -19.6% | 3百万 -95.5% | 93百万 -37.2% | 260百万 -31.8% | |
| 2024/09 | 46百万 -6.1% | 104百万 -9.6% | 72百万 +999.99% | 108百万 +16.1% | 330百万 +26.9% | |
| 2025/09 | 9百万 -80.4% | 92百万 -11.5% | 36百万 -50% | 164百万 +51.9% | 301百万 -8.8% | |
| 2026/09 *ヶ月 | 10百万 +11.1% | 49百万 -46.7% | - | - | - | |
| 営業利益率 | 2014/09 | -47.3% | 11.7% | -11.8% | -6.1% | -7.6% |
| 2015/09 | -51.7% 赤字 | -2.3% 赤字 | -22.1% 赤字 | -7.4% 赤字 | -12.6% 赤字 | |
| 2016/09 | -63.4% 赤字 | 2.7% | -10.6% 赤字 | 8.2% | -3.3% 赤字 | |
| 2017/09 | -8.8% 赤字 | 11.2% +8.5% | 3.8% | 10.6% +2.4% | 7.2% | |
| 2018/09 | -44.7% 赤字 | 9.4% -1.8% | 16.9% +13.1% | 2.2% -8.4% | 6.7% -0.5% | |
| 2019/09 | -3.6% 赤字 | 13.3% +3.9% | -3.6% 赤字 | 4.9% +2.7% | 3.4% -3.3% | |
| 2020/09 | 5.9% | 11.8% -1.5% | -37.3% 赤字 | 4.5% -0.4% | 0.5% -2.9% | |
| 2021/09 | 9.6% +3.7% | 10.5% -1.3% | -6.7% 赤字 | 13.9% +9.4% | 8.5% +8% | |
| 2022/09 | 12.2% +2.6% | 18.4% +7.9% | 9.1% | 14.8% +0.9% | 14.1% +5.6% | |
| 2023/09 | 14.8% +2.6% | 12.9% -5.5% | 0.7% -8.4% | 12.3% -2.5% | 10.9% -3.2% | |
| 2024/09 | 13.1% -1.7% | 15.5% +2.6% | 8.5% +7.8% | 14.5% +2.2% | 12.6% +1.7% | |
| 2025/09 | 3% -10.1% | 13.2% -2.3% | 7.2% -1.3% | 14% -0.5% | 11.3% -1.3% | |
| 2026/09 *ヶ月 | 3.2% +0.2% | 6.5% -6.7% | - | - | - | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
